Aortic stiffness as a marker of cardiac function and myocardial strain in patients undergoing aortic valve replacement

Journal of Cardiothoracic Surgery

Thanos Athanasiou⁴  Paul Evans³  Darrel P Francis¹  Hatam Naase⁴  Hutan Ashrafian²  Leanne Harling⁴  Emaddin Kidher⁴ 

[1] International Centre for Circulatory Health, Imperial College Healthcare NHS Trust, St Mary’s Hospital, London, UK;The Department of Surgery and Cancer, Imperial College London, St Mary’s Hospital, 10th Floor, QEQM Wing, St Mary’s Campus, London W2 1NY, UK;Department of Cardiovascular Science, University of Sheffield, Sheffield, UK;Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK

关键词: AVR;    Aortic valve replacement;    BNP;    B-type natriuretic peptide;    Myocardial strain;    PWV;    Aortic stiffness;    Pulse wave velocity;   

Others  :  804577
DOI  :  10.1186/1749-8090-9-102

 received in 2014-04-13, accepted in 2014-06-12,  发布年份 2014

【 摘 要 】

Background

Cardiac function and myocardial strain are affected by cardiac afterload, which is in part due to the stiffness of the aortic wall. In this study, we hypothesize that aortic pulse wave velocity (PWV) as a marker of aortic stiffness correlates with conventional clinical and biochemical markers of cardiac function and perioperative myocardial strain in aortic valve replacement (AVR).

Methods

Patients undergoing AVR for aortic stenosis between June 2010 and August 2012 were recruited for inclusion in this study. PWV, NYHA class and left ventricular (LV) function were assessed pre-operatively. PWV was analysed both as a continuous and dichotomous variable according to age-standardized reference values. B-type natriuretic peptide (BNP) was measured pre-operatively, and at 3 h and 18-24 h after cardiopulmonary bypass (CPB). NYHA class, leg edema, and LV function were recorded at follow-up (409 ± 159 days).

Results

Fifty-six patients (16 females) with a mean age of 71 ± 8.4 years were included, with 50 (89%) patients completing follow-up. The NYHA class of PWV-norm patients was significantly lower than PWV-high patients both pre- and post-operatively. Multiple logistic regression also highlighted PWV-cut off as an independent predictor of NYHA class pre- and post-operatively (OR 8.3, 95%CI [2.27,33.33] and OR 14.44, 95%CI [1.49,139.31] respectively). No significant relationship was observed between PWV and either LV function or plasma BNP.

Conclusion

In patients undergoing AVR for aortic stenosis, PWV is independently related to pre- and post-operative NYHA class but not to LV function or BNP. These findings provisionally support the use of perioperative PWV as a non-invasive marker of clinical functional status, which when used in conjunction with biomarkers of myocardial strain such as BNP, may provide a holistic functional assessment of patients undergoing aortic valve surgery. However, in order for PWV assessment to be translated into clinical practice and utilised as more than simply a research tool, further validation is required in the form of larger prospective studies specifically designed to assess the relationship between PWV and these functional clinical outcomes.

【 授权许可】

   
2014 Kidher et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH: Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 2011, 57:1511-1522.
• [2]Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H: Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27:2588-2605.
• [3]Lee HY, Oh BH: Aging and arterial stiffness. Circ J 2010, 74:2257-2262.
• [4]O'Rourke MF: How stiffening of the aorta and elastic arteries leads to compromised coronary flow. Heart 2008, 94:690-691.
• [5]Ohmori K, Emura S, Takashima T: Risk factors of atherosclerosis and aortic pulse wave velocity. Angiology 2000, 51:53-60.
• [6]Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ: Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010, 121:505-511.
• [7]Vlachopoulos C, Aznaouridis K, Stefanadis C: Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010, 55:1318-1327.
• [8]Collaboration TRVfAS: Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J 2010, 31:2338-2350.
• [9]Gerber IL, Stewart RA, Legget ME, West TM, French RL, Sutton TM, Yandle TG, French JK, Richards AM, White HD: Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 2003, 107:1884-1890.
• [10]Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H, Binder T, Pacher R, Maurer G, Baumgartner H: Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004, 109:2302-2308.
• [11]Kefer J, Beauloye C, Astarci P, Renkin J, Glineur D, Dekleermaeker A, Vanoverschelde JL: Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation. Am J Cardiol 2010, 106:1782-1786.
• [12]Yambe M, Tomiyama H, Koji Y, Motobe K, Shiina K, Gulnisia Z, Yamamoto Y, Yamashina A: B-type natriuretic peptide and arterial stiffness in healthy Japanese men. Am J Hypertens 2006, 19:443-447.
• [13]Chatzis D, Tsioufis C, Tsiachris D, Taxiarchou E, Lalos S, Kyriakides Z, Tousoulis D, Kallikazaros I, Stefanadis C: Brain natriuretic peptide as an integrator of cardiovascular stiffening in hypertension. Int J Cardiol 2010, 141:291-296.
• [14]Sakuragi S, Okawa K, Iwasaki J, Tokunaga N, Kakishita M, Ohe T: Aortic stiffness is an independent determinant of B-type natriuretic peptide in patients with coronary artery disease. Cardiology 2007, 107:140-146.
• [15]van Elderen SG, Brandts A, Westenberg JJ, van der Grond J, Tamsma JT, van Buchem MA, Romijn JA, Kroft LJ, Smit JW, de Roos A: Aortic stiffness is associated with cardiac function and cerebral small vessel disease in patients with type 1 diabetes mellitus: assessment by magnetic resonance imaging. Eur Radiol 2010, 20:1132-1138.
• [16]Mendonca MI, Reis RP, Sousa AC, Gomes S, Faria P, Pereira A, Silva B, Serrao M, Santos N, Sousa FS, Silva JA, Sousa J, Ornelas I, Freitas S, Cardoso A, Araujo JJ: Pulse wave velocity and coronary risk stratification. Rev Port Cardiol 2009, 28:155-171.
• [17]Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U: EuroSCORE II. Eur J Cardiothorac Surg 2012, 41:734-744. discussion 744–735
• [18]Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A: Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002, 39:202-209.
• [19]Mair J, Hammerer-Lercher A, Puschendorf B: The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001, 39:571-588.
• [20]The Criteria Committee of the New York Heart Association: Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th edition. Boston: Little, Brown & Co; 1994.
• [21]Pierard S, de Meester C, Seldrum S, Pasquet A, Gerber B, Vancraeynest D, Robert A, El Khoury G, Noirhomme P, Vanoverschelde JL: Impact of preoperative symptoms on postoperative survival in severe aortic stenosis: implications for the timing of surgery. Ann Thorac Surg 2014, 97:803-809.
• [22]Kuwaki K, Amano A, Inaba H, Yamamoto T, Matsumura T, Dohi S, Matsushita S: Predictors of early and mid-term results in contemporary aortic valve replacement for aortic stenosis. J Card Surg 2012, 27:139-145.
• [23]Raphael C, Briscoe C, Davies J, Ian Whinnett Z, Manisty C, Sutton R, Mayet J, Francis DP: Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 2007, 93:476-482.
• [24]Flores-Marin A, Gomez-Doblas JJ, Caballero-Borrego J, Cabrera-Bueno F, Rodriguez-Bailon I, Melero JM, Porras C, Sanchez-Espin G, Such M, Olalla E, de Teresa E: Long-term predictors of mortality and functional recovery after aortic valve replacement for severe aortic stenosis with left ventricular dysfunction. Rev Esp Cardiol 2010, 63:36-45.
• [25]Bonapace S, Rossi A, Cicoira M, Golia G, Zanolla L, Franceschini L, Conte L, Marino P, Zardini P, Vassanelli C: Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy. Am Heart J 2006, 152:93. e91-96
• [26]Sun WP, Wu YQ, Li J, Hu DY: Relationship between pulse wave velocity and the NYha classification of coronary insufficiency. Zhonghua Nei Ke Za Zhi 2008, 47:382-384.
• [27]Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbely A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL: How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007, 28:2539-2550.